-
May 13 |
Diagnostics World | For diagnostic labs, 2025 is a “big, complicated year” that began with a milestone “win” for laboratories when a U.S. District Court decision vacated a Food and Drug Administration (FDA) final rule that would have regulated all laboratory-developed tests (LDTs) as medical devices. Despite that win, there is no shortage of concerns and challenges facing the industry, including unknowns about the final shape of the federal reconciliation package on Capitol Hill.
More
-
May 08 |
Diagnostics World | The stethoscope, despite being more than 200 years old, is not an easily retired diagnostic device. It remains symbolic of the medical profession, even if many physicians no longer wear them and those that do are not particularly good at using them.
More
-
May 06 |
Diagnostics World | Cleveland Diagnostics announced the results of a new independent study published in Urology; Illumina and Tempus AI collaborate to accelerate clinical adoption of next-generation sequencing tests through novel evidence generation; LinusBio announced a new partnership with the BRAIN Foundation to support advancing autism biomarker research and facilitating early identification and intervention of autism spectrum disorder; and more.
More
-
May 02 |
Diagnostics World | One of the most important tools we have to reduce mortality from cancer is early detection. Mammograms have had a significant impact in improving outcomes for patients with breast cancer, and colonoscopies have done the same for patients with colorectal cancer. But despite broad recognition of the importance of early cancer detection, our ability to screen for a wide range of cancers is quite limited. In fact, there are only five cancers for which Medicare is directed to pay for screening: breast, cervical, colon, lung, and prostate.
More
-
Apr 30 |
Diagnostics World | Cleveland Diagnostics announced the results of a new independent study published in Urology; Illumina and Tempus AI collaborate to accelerate clinical adoption of next-generation sequencing tests through novel evidence generation; LinusBio announced a new partnership with the BRAIN Foundation to support advancing autism biomarker research and facilitating early identification and intervention of autism spectrum disorder; and more.
More
-
Apr 29 |
Diagnostics World | Atsena will advance their lead program, ATSN-201, for the treatment of a genetic condition that is typically diagnosed in childhood and leads to blindness later in life; Merida Biosciences plan to develop antibody-like therapeutics to help treat multiple diseases; and more.
More
-
Apr 23 |
Diagnostics World | Over the past few years, a multidisciplinary team of experts has been spreading the news that an abnormality of the heart’s left atrium (LA), known as LA myopathy, can be a marker of elevated risk of stroke and dementia—even in the absence of atrial fibrillation (AFib). The current “gap in the field” is that there is no established way to characterize the condition.
More
-
Apr 22 |
Diagnostics World | The clinical relevance and limitations of so-called “lab-in-a-box” (LIAB) diagnostics, which surged in popularity during the COVID pandemic, have since that time been under considerable scrutiny, most notably among investors still spooked by the notorious Theranos scandal. One of the more enduring problems among LIAB developers is that they tend to get “blinded by the beauty” of their technology.
More
-
Apr 17 |
Diagnostics World | Researchers at The University of Texas at El Paso (UTEP) are developing a point-of-care device for diagnosing colorectal cancer which, like blood glucose devices, uses electrochemical sensors. The microchip electrode features an immunosensor that detects disease biomarkers in a drop of blood, opening the possibility of an accessible, inexpensive test for the nation’s second leading cause of cancer-related deaths.
More
-
Apr 16 |
Diagnostics World | Magnetic flexible endoscopes (MFEs) have up to now had a few disadvantages limiting their use inside the human body for performing virtual biopsies, notably navigation-related difficulties related to their traditional cylindrical shape. These robot-assisted devices use magnetic forces to propel and maneuver through lumens like the colon, but rotation happens in only two directions that limits the scope's ability to effectively perform procedures.
More
-
Sep 25 |
PRINCETON, NJ - Sep 25, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced that the US Food and Drug Administration (FDA) has renewed its legacy licenses for Synchrogenixs electronic Common Technical Document (eCTD) review software, GlobalSubmit REVIEW and GlobalSubmit VALIDATE for another year
More
-
Sep 24 |
PHILADELPHIA, PA, UNITED STATES - Sep 24, 2019 - Proscia, a leading provider of digital pathology software, has been granted U.S. Patent No. 10,346,980 by the United States Patent and Trademark Office (USPTO)
More
-
Sep 24 |
ROYSTON, UK - Sep 24, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has joined UK Medicines Discovery Catapults Discovery Services Platform, partnering with other best-in-class service providers to help improve preclinical drug discovery success rates
More
-
Sep 17 |
, UK - Sep 17, 2019 - QuantuMDx Group Limited, a UK-based life sciences company developing transformational point of care diagnostics, is pleased to announce Neil Butler has joined its Board as an Independent Non-Executive Director
More
-
Sep 17 |
PRINCETON, NJ - Sep 17, 2019 - The WIRB-Copernicus Group®s (WCG) Clinical Services Division is pleased to announce that enrollment in WCG KMR Groups 2019 Clinical Trial Cost Study is now open
More
-
Sep 17 |
PRINCETON, NJ - Sep 17, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the launch of Hasharc, its decentralized application (DApp) for healthcare, built in conjunction with the Hedera public Distributed Ledger Technology (DLT)
More
-
Sep 12 |
HONOLULU, HI, UNITED STATES - Sep 13, 2019 - Honolulu, HI (September 13, 2019) - A recently released workforce supply and demand study conducted by the Healthcare Association of Hawaii (HAH) reveals a need for phlebotomists in the state
More
-
Sep 12 |
CAMBRIDGE, MA - Sep 12, 2019 - Shimmer Research, a global leader in wearable technology for research applications, today announced the launch of a healthcare industry open source initiative for wearable sensor algorithms
More
-
Sep 12 |
PRINCETON, NJ - Sep 12, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the launch of Phoenix® 8
More
-
Sep 11 |
ROYAL OAK, MI, UNITED STATES - Sep 11, 2019 - OncoCell MDx, Inc., a pan-disease immunogenomics platform company developing novel noninvasive blood-based tests to optimize patient care, today announced it has raised $22
More
View more articles